COMMUNIQUÉS West-GlobeNewswire
-
Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension
28/08/2025 -
International Observers Raise Concerns Over Judicial Irregularities in Senegal; Rights Advocates Stress Importance for Governance and Investment
28/08/2025 -
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock
28/08/2025
Pages